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1. SUMMARY 
Before modern medical advances, the predominant standard in determination of human 
death was the traditional cardiopulmonary standard: the irreversible loss of heart and lung 
function. However, as a response to certain advances in intensive care medicine, since the 
late 20th century, a new standard for determination of human death has been introduced and 
accepted in both the medical and legal communities in many parts of the world. This new 
standard, which took its place alongside the traditional one, is based on the irreversible loss 
of all bilateral brain hemispheric and brain stem dependent functions in a heart-beating and 
ventilator-supported patient, known as brain death (BD).  
  In most human deaths, irreversible cessation of all functions of the entire brain, 
including the brain stem, is accompanied by the traditional, familiar signs of death: the 
patient stops breathing, his or her heart stops beating, and the body starts to decompose. In 
relatively rare cases, however, the irreversible loss of brain-dependent functions occurs 
while the body, with medical and mechanical assistance, continues to circulate blood and to 
show other signs of life. Thus, BD is a byproduct of the modern intensive care, which 
became defined by the Harvard Medical School ad Hoc Committee (1968). However, both 
the definition of BD and diagnostic criteria have undergone a substantial evolution. Despite 
the fact that BD, as a concept, is now widely accepted all over the world and the certainty of 
its diagnosis, when carefully formulated, is still being doubted. It’s definition as well as 
diagnostic criteria are far from being perfect and require further adjustments. 
  This review presents the historical development of the concept of brain death, 
current clinical and ancillary tests used during attempt to determine a diagnosis of BD, 
responsibility of declaring dead a “corpse with a beating heart”, as well as two typical clinical 
cases, which illustrate the clinical process of legal determination and certification of human 
death in the Republic of Croatia. 
 
 
      Key words: ancillary diagnostic tests, brain death, clinical diagnostic tests, intensive care  
 
 
 
1. SAŽETAK 
Prije ere suvremenih medicinskih dostignuća, standardno određivanje smrti kod čovjeka se  
baziralo na tradicionalnom kardio-respiratornom konceptu: nepovratan prestanak fukcije 
srca i pluća. Međutim, zahvaljujući razvoju medicinskog tretmana u jedinicama intenzivne 
njege i rehabilitacije od druge polovice 20-og stoljeća definiran je novi koncept za 
određivanje smrti kod pacijenata, koji je medikolegalno postepeno prihvaćen širom svijeta. 
Taj novi koncept za definiciju smrti, baziran na nepovratnom gubitku funkcija mozga i 
moždanog debla kod pacijenata koji imaju očuvanu spontanu srčanu funkciju, ali su bez 
adekvatne repiratorne funkcije i zbog toga su tretirani sa mehaničkom plućnom ventilacijom, 
poznata je kao moždana smrt.  
  U većine smrtnih slučajeva, nepovratni prestanak svih moždanih funkcija, 
uključujući funkcije moždanog debla, udružen je s tradicionalnim znacima smrti: prestanak 
disanja sa prestankom srčane radnje i multiorganskim zatajenjem. Međutim, u relativno 
rijetkim slučajevima, može se desiti nepovratni gubitak moždanih funkcija u pacijenata koji 
zahvaljujući modernom intenzivnom tretmanu imaju druge znakove života kao na primjer 
očuvanu kardiocirkulatornu funkciju. Drugim riječima to znači da je moždana smrt jedan 
popratni efekt moderne intenzivne terapije kako je definirano od Harvard Medical School ad 
Hoc Committee (1968). Ipak, definicija moždane smrti i dijagnostički kriteriji su tijekom 
vremena doživjeli bitnu evoluciju. Unatoč tome što je moždana smrt danas prihvaćen 
koncept širom svijeta i što je dijagnoza jasna, oboje, i njena definicija i dijagnostički kriteriji 
ne se mogu smatrati savršenim I zahtijevaju dodatna unaprijeđenja. 
  Ovaj rad prikazuje povijesni razvoj koncepta moždane smrti, aktualne kliničke i 
parakliničke dijagnostičke testove, odgovornost u procesu proglašavanja smrti u pacijenata 
sa očuvanom kardiocirkulatornom funkcijom koji su bez respiratorne funkcije, kao i dvije 
tipične kliničke situacije u dva pacijenta koje ilustriraju klinički proces legalnog proglašavanja 
i  potvrde smrti u Republici Hrvatskoj.   
 
      Ključne riječi: Intenzivna njega, klinički dijagnostički testovi, moždana smrt, paraklinički 
      dijagnostički testovi. 
1. PREFACE 
As a response to certain advances in intensive care medicine, the late 20th century 
introduced a new standard for determining death, which became accepted in both the 
medical and legal communities in many parts of the world. Until then, the predominant 
standard in determination of human death was the traditional cardiopulmonary standard: the 
irreversible loss of heart and lung functions. The new standard, which took its place 
alongside the traditional one, is based on the irreversible loss of all brain-dependent 
functions. In most human deaths, the loss of these neurological functions is accompanied by 
the traditional, familiar signs of death: the patient stops breathing, his or her heart stops 
beating, and the body starts to decompose. In relatively rare cases, however, the irreversible 
loss of brain-dependent functions occurs while the body, with medical and mechanical 
assistance, continues to circulate blood and to show other signs of life.  
 When physicians suspect an irreversible loss of brain function in a heart-beating and 
ventilator supported patient, BD diagnostic criteria are applied. This review presents the 
historical development of the concept of brain death, current clinical and ancillary tests used 
during attempt to determine a diagnosis of brain death, as well as two typical clinical cases 
which illustrate the clinical process of legal determination and certification of human death in 
Croatia. 
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2. Current definition of human death and its legal determination  
 
Long before the advent of modern medical technology in the middle of the 20th century, death 
was considered to have occurred when the heartbeat and breathing irreversibly ceased. This 
cardiorespiratory view of life and death was supported when the French physician, Rene 
Laёnnec, invented the stethoscope in 1819 (Adler 1981), and another French physician, 
Eugene Bouchut, first applied this device to the diagnosis of death in 1846 (Bouchut 1849). 
This advance contributed to the public’s fear of premature burial to decrease to some extent 
(Pernick 1988).  
Currently, cardiac arrest is determined in the field by the absence of a 
spontaneous pulse palpated at a carotid, and by the auscultation of the main four 
auscultation points on the chest (aortic, pulmonic, tricuspid and mitral valves). It can also be 
determined by the presence of ventricular fibrillation or asystole using an 
electrocardiographic monitor. Respiratory arrest is determined in the field by the absence of 
effective, spontaneous ventilation, assessed by inspection and auscultation. The diagnosis of 
death can be made if a cardiorespiratory arrest of at least 5 minutes is demonstrated, 
excluding hypothermia. Nonetheless, if an effective mechanical cardiorespiratory reanimation 
is applied, or neuroprotective methods are used (such as controlled hypothermia) this 5-
minute period could be increasingly prolonged. 
By the end of the 19th century, listed drugs that could induce apparent death, 
included atropine, curare, cyanide, amylnitrate, chloral hydrate and pure oxygen (Richardson 
1879,1888). This evidence together with identified disorders and states, including suffocation, 
stroke, head injury, hypothermia, intoxication by alcohol, opiates or hypnotic drugs, catalepsy 
or hypnotic trance, that mimic death challenged the traditional concept of death (Machado 
2007a). Moreover, new inventions, developing and successful use of effective techniques of 
cardiopulmonary resuscitation, such as the cardiac defibrillator to recover heartbeat after 
cardiac arrest (Pernick 1988, Meyer 1988, Zoll et al. 1955), and the mechanical respiration 
device to support ventilation (Edmonson 1982, Maxwell 1986) undermined the physician’s 
ability to diagnose death using the traditional concept (Machado 2007). 
At the end of the 1950s and during the 1960s, increased use of artificial 
cardiopulmonary support as well as improvements in critical care and growing need for 
transplantable organs radically changed the course of the practical and the ethical debates 
about continued support for patients without brain function (Machado 2007a).  In the 
meantime, some reports appeared about a condition in which the brain was massively 
damaged and nonfunctional while other organs remain functioning (Machado 2007a). This 
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drove the efforts to define death based on neurological criteria and brain death (BD) was 
gradually accepted as death of the individual (Pernick 1988, Wijdicks 2001a, b).  Currently, 
when physicians suspect an irreversible loss of brain function in a heart-beating and 
ventilator supported patient, BD diagnostic criteria are applied. To assess brain function 
during BD diagnostics, the clinical neurological examination is the accepted standard (Table 
1). 
In 1980, The Uniform Determination of Death Act (UDDA) in USA proposed a 
legal definition of human death, which has since been widely accepted. The act reads: “An 
individual, who has sustained either irreversible cessation of circulatory and respiratory 
functions, or irreversible cessation of all functions of the entire brain, including the brain stem, 
is dead.” The latter is defined as BD. Thus, a patient determined to be brain dead is clinically 
and legally dead (Spinello 2015). However, diagnosing of human death, based on findings of 
irreversible loss of respiratory, cardiocirculatory and brain functions is not related to the 
concept that there are different types of death. The irreversible loss of respiratory and 
cardiocirculatory functions can only cause death when ischemia and anoxia are prolonged 
enough to produce an irreversible destruction of the brain. According to this concept there is 
only one kind of death, based on the irreversible loss of brain function (Machado 2007b).   
The signs of human death related to forensic medicine circumstances, algor 
mortis (postmortem coldness), livor mortis (postmortem lividity), rigor mortis (postmortem 
rigidity), cadaveric spasm, loss of muscle contractions and putrefaction, are beyond the 
scope of this review.  
            
3. Historical perspective of the brain death concept  
 
At the end of the 19th century and beginning of the 20th century, several neurosurgeons 
reported that there was provoked respiratory arrest with continuation of heart beats, in 
patients having an increase of intracranial pressure (ICP), e.g. in those with brain abscesses, 
cerebral hemorrhage, brain tumors and depressed fractures of the skull. This state in fact 
resembles what would today be recognized as BD (Machado 2007a).  Although these reports 
provide early descriptions of the brain death syndrome, these neurosurgeons still considered 
cessation of respiration or heartbeat to be the sign of death. 
 Thus, the concept of BD and its determination remained unclear for almost a half-
century. During that time, many important discoveries were made describing states of 
irreversible coma after severe brain injury, and advances in life-sustaining therapies were 
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used to keep patients with irreversible coma after severe brain injury “alive” for extended 
periods of time (Schwab et al. 1963).  
 After the discovery of the electroencephalogram by Hans Berger in 1924 in Germany 
(Gloor 1969), George Washington Crile proposed in 1930 a definition of death as a drop in 
electric potentials between the brain and other organs and tissues (Crile et al. 1930) and in 
1938 electroencephalography (EEG) was used to show loss of brain potentials after anoxia in 
animals (Sugar & Gerard 1938). 
After the introduction of the first cerebral angiography technique in 1927 by 
Egas Moniz and Almeida Lima from Lisbon (Tandreau 1985), neuroradiologists and 
neurosurgeons at the end of the 1950s recognized cessation of cerebral blood flow, referred 
to as cerebral circulatory arrest, by angiography. This angiographic imaging was identified in 
apneic or comatose patients after head injury, intracranial hemorrhage, or other space 
occupying brain lesions (Settergren 2013).             
  In 1959, Mollaret and Goulon coined the term coma dépassé for an irreversible state 
of coma and apnea (Mollaret & Goulon 1959). Based on 23 cases, they described a condition 
of deep coma with no spontaneous respiration, no reflexes, polyuria, hypotension if 
norepinephrine was not given continuously, and the absence of all EEG activity. They stated 
that if the ventilation or the infusion of norepinephrine were stopped, the cardiac arrest would 
follow and the patient would rapidly die. Despite treatment the patients died from cardiac 
arrest usually within days after the deep coma had been established. Although this article 
was a breakthrough contribution to the description of brain death, these authors did not 
believe in the death of the nervous system. They considered the concept of cardiac death to 
be the defining phenomenon, generating a major controversy (Machado 2007a).   
 First in 1959, Pierre Wertheimer’s group characterized the “death of the nervous 
system” and went further to propose stopping the ventilator if death of the nervous system 
was diagnosed clinically and by “the repeatedly verified absence of EEG activity both in the 
cortex and in the diencephalon, and if resuscitative efforts have been given enough time, 18 
to 24 hours” (Wertheimer et al. 1959). 
In 1963, Robert Schwab et al. (Schwab et al. 1963) stated that “the total 
absence of EEG activity after 30 min of recording is the most important evidence of death of 
the nervous system.” This was also among the first accepted diagnostic criteria of human 
death on neurological grounds in the presence of a beating heart, and the authors went 
further than just EEG findings, as an ancillary test, would be incorporated into diagnostic 
criteria. The Schwab’s proposed criteria for establishing brain death are presented in Table 1.  
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           The 1968 report of the Ad Hoc Committee of the Harvard Medical School to Examine 
the Definition of Brain Death was the first attempt to define brain death as the irreversible 
loss of all brain function, both cerebral and brain stem, and to present the criteria required for 
the diagnosis (Beechler 1968). The criteria included irreversible coma, as unresponsiveness 
and lack of receptivity, whose cause has been identified, absence of movement and 
breathing, absence of brain stem reflexes, with an isoelectric EEG, and no changes in these 
findings after at least 24 hours of observation, as presented in Table 1. In the same year, the 
Harvard criteria were presented at the World Medical Assembly in Sydney, and essential 
statements on human death were released. The Harvard Report had momentous 
repercussions and constituted a breakthrough account, establishing a paradigm for defining 
death by neurological criteria that were widely accepted, and later somewhat improved by 
Wijdicks (Wijdicks 2001a, b) as presented in Table 1.  However, despite the fact that the 
definition of human death based on neurological criteria, BD, was accepted worldwide, there 
was no global consensus in diagnostic criteria (Wijdicks 2002).   
 
Table 1. Comparison of Schwab’s criteria, Harvard criteria and Wijdicks criteria for diagnosing 
of brain death in adults (for explanation, see text). 
Schwab’s Criteria, 1963 Harvard Criteria,1968 Wijdicks Criteria,2001 
Precondition: Precondition: 
1. Ireversible cerebral damage  
2. Exclusion of  
   a) Hypothermia (below 90F)  
   b) Central nervous system depressants, 
such as barbiturates 
Preconditions or prerequisites: 
1. Coma due to an irreversible acute brain 
damage of known etiology; affecting both 
hemispheres and brainstem 
2. At the time of beginning neurological 
examination, the following confounding 
factors should be excluded: 
  a) Unresuscitated shock; systolic arterial 
pressure should be over 90 mmHg 
   b) Hypotermia (core temperature <34C 
   c) Severe metabolic disorders capable of 
causing a potentially reversible coma 
   d) Peripheral nerve or muscle 
dysfunction, and neuromuscular blockade 
   e) Evidence of drug intoxication or 
poisoning 
Diagnostic criteria: 
 
 
Diagnostic criteria: 
1. Unreceptivity and unresponsiveness to 
even the most intensely painful stimuli  
Diagnostic criteria: 
1. Deep unresponsive coma 
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1. No pupillary reflexes and 
the pupils must be dilated 
2. Eyeball pressure must not 
change the heart rate 
 
 
 
 
3. Spontaneous respiration 
must be absent for at least 30 
minutes, 
 
4. There must be no tendon 
reflexes of any type 
 
 
 
 
 
 
 
 
 
 
 
5. Confirmatory tests 
 
 
 
● The electroencephalography 
(EEG) should show flat lines 
without any rhythms in all 
leads over a 30-minute period 
● A loud noise must not 
produce any detectible 
discharge in the EEG 
2. Absent brainstem reflexes 
    ● Corneal response 
    ● Pupil fixed and dilated and will not 
respond to a direct source of bright light 
    ● Oculocaphalic and oculovestibular 
responses 
    ● pharyngeal reflexes 
3. Swallowing, yawning, vocalizations are 
in abeyance 
 
4. No movement or breathing 
 
5. There is no evidence of postural activity 
(decerebrate or other) 
6. As a rule, the stretch of (sic) tendon 
reflexes cannot be elicited 
7. Plantar or noxious stimulation gives no 
response 
8. Observation covering a period of at least 
1 hour by physicians are adequate to 
satisfy the criteria of no spontaneous 
muscular movements or spontaneous 
respiration (established by turning off the 
respirator for 3 minutes) or response to 
stimuli such as pain, touch, sound, or light) 
9. All of the above tests shall be repeated 
at least 24 hours later with no change 
10. Confirmatory tests 
 
 
 
     ● Flat electroencephalography (EEG) 
(when available it should be utilized) 
2. Absent brainstem reflexes 
   ● Corneal responses 
   ● Pupillary responses to light with pupils 
at mid-size or greater 
   ● Oculocaphalic and oculovestibular 
responses 
   ● Gag and cough responses 
3. Negative atropine test 
 
 
4. Absent respiratory effort confirmed by 
the apnea test 
 
 
 
 
 
 
5. Periods of observation. 6 hours; in case 
of acute hypoxic-ischemic brain injury, 
clinical evaluation should be delayed for 
24 hours subsequent to the 
cardiorespiratory arrest or an ancillary test 
could be performed 
 
 
 
6. Confirmatory tests 
    ● Tests to demonstrate a complete 
cessation of brain circulation: Transcranial 
Doppler (TCD) ultrasonography 
    ● Confirmatory tests to demonstrate loss 
of bioelectrical activity: 
electroencephalography (EEG), evoked 
potentials (EP), and electroretinography 
(ERG) 
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Schwab’s Criteria, 1963 (Schwab et al. 1963), as stated in the review (Machado 2007b); Harvard Criteria, 1968 (Beechler 
1968) ; and Wijdicks Criteria, 2001 (Wijdicks 2001a, b) 
 
4. Clinical diagnosis of brain death  
 
As has already been emphasized, when a physician suspects an irreversible loss of brain 
function in a heart-beating and ventilator supported patient, BD diagnostic criteria are 
applied. To assess brain function during BD diagnostics, the clinical neurological examination 
is the accepted standard (Table 1). While any physician should be able to diagnose BD, in 
practice, the physician who performs the exam and renders the diagnosis must adhere to 
strict professional standards. The physician must be competent to perform the clinical exam 
and interpret the results, as well as be free of even the appearance of conflict of interest. 
Physicians, who procure either harvest organs of brain dead donor or are otherwise actively 
involved in an organ transplant program, must not determine BD. 
           The physician must determine the cause of coma and whether the symptoms are 
irreversible. If one cannot determine the initiating cause, one must know how to establish that 
the patient has passed into an irreversible condition. Bilateral cerebral hemispheric and brain 
stem function must be absent. One must know if and when to repeat the examination and 
when to obtain confirmatory exams. Since most institutions have clinical practice guidelines 
that define BD and detail the requirements for determination of BD, physicians must know the 
policy of their individual hospitals. If a policy proves old and no longer matches current 
understanding, one should work to update it. Finally, the physician must know the pitfalls in 
rendering the diagnosis. 
 
6.1 Causes of brain damage and irreversible loss of brain function 
 
The diagnosis of BD requires demonstration of the irreversible cessation of cerebral 
hemispheric and brain stem function. Determination of irreversibility requires knowledge of 
the cause of coma and the likelihood that it will result in BD.  Such causes include severe 
brain injury, anoxic encephalopathy, and metabolic disease, which can generate 
uncontrollable cerebral edema. 
Hence, clinical and radiological evidence and history of non-survivable brain 
injury must be documented. Radiological examinations, such as computed tomography (CT) 
and magnetic resonance imaging (MRI), of the brain can rapidly reveal devastating structural 
lesions and pathological changes causing irreversible loss of consciousness with terminal 
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brain herniation. When the cause of the coma is unknown or potentially reversible, the 
irreversible decline to BD can be demonstrated by clinical exam, appropriate period of 
observation, and confirmatory tests. 
 
6.2 Confounding factors to be excluded 
   
Clinical states that may mimic brain death, and potentially reversible causes of apparent 
marked depression of consciousness or responsiveness (Table 1 and Table 2), must be ruled 
out (Wijdicks 2001a, Wijdicks et al. 2010, Morenski et al. 2003, Hills 2010,  Arbour 2013).  
 
6.2.1. Unresuscitated shock 
Neurological assessments may be unreliable in the acute post-resuscitation phase after 
cardiorespiratory arrest. Moreover, the presence of unstable blood pressure has also been 
reported in BD. Hence, it is indispensible to apply BD criteria only with a systolic blood 
pressure minimum value of 90 mmHg. The use of hydration fluids or vasopressor drugs might 
reestablish adequate blood pressure values. 
 
6.2.2. Hypothermia  
An inability to regulate temperature, or poikilothermia, is often present in BD. Core 
temperature results should be obtained through central blood, rectal or esophageal gastric 
measurement. Most sets of criteria for BD diagnosis require a body temperature of at least 
32.2C. It was stated that hypothermia below 32C is one of the best signs of total BD. The 
correction of hypothermia before applying criteria of BD is appropriate, especially in children 
and alcoholic patients who become hypothermic after mild brain injuries. Moreover, it is 
important for physicians to be aware of subjects undergoing accidental hypothermia 
(immersion/submersion in cold water, snow avalanche or prolonged exposure to cold 
surroundings). 
 In contrast, it was stated that hyperthermia during the post-resuscitation period after 
cardiac arrest is an early indicator of brain damage and poor prognosis, highly correlated with 
an evolution to BD.  
 
6.2.3. Severe metabolic disorder capable of causing a potentially reversible coma 
Severe metabolic or endocrine abnormalities make BD unreliable. Metabolic or endocrine 
derangements, including glucose, electrolytes (phosphate, calcium and magnesium), inborn 
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errors of metabolism, and liver or renal dysfunction, may cause a potentially reversible coma. 
If in the treating physician’s judgment the metabolic abnormality may play a role, it should be 
corrected. 
 
Table 2. Clinical states that may mimic brain death, and potentially reversible causes of 
apparent marked depression of consciousness or responsiveness.  
Drug intoxication 
          Residual effects of central nervous system depressants 
          Residual effects of neuromuscular blocking agents      
          Residual effects of ethanol and other recreational drugs 
Metabolic intoxication 
     Failure of metabolism 
          Hypothermia (Brain stem reflexes fail at core body temperatures below 32° C) 
          Hypoxia / Global Hypoxemia (Anoxic/Ischemic Encephalopathy)  
          Hypoglycemia (Metabolic Toxic Encephalopathy) 
     Physiologic derangements 
          Hyperglycemia / Hyperosmolar state 
          Pituitary insufficiency / Hypocortisolism  
          Adrenal insufficiency 
          Hyponatremia / Hypernatremia 
          Hypocalcemia / Hypercalcemia 
          Hypomagnesemia / Hypermagnesemia      
          Hypothyroidism / Hyperthyroidism 
          Arterial hypotension 
     Toxic 
          Hypercarbia/Hypocarbia 
          Sepsis 
          Meningitis / Encephalitis 
          Liver / Renal failure (Renal / Hepatic encephalopathy) 
          Carbon monoxide / Heavy metal exposure 
          Pesticide / Organophosphate exposure 
          Chemical nerve agent exposure 
          Severe snake envenomation 
Clinical state 
     Fulminant Guillain-Barré syndrome 
     Non-convulsive Status Epilepticus 
     Brain trauma / Brain edema 
     Subarachnoid hemorrhage 
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     Hydrocephalus / Brain abscess 
     Direct / Indirect compression of the brain stem 
     Traumatic / Hemorrhagic lesion affecting the ascending Reticular Activating System 
     Post-cardiac arrest syndrome 
     Psychogenic coma / Catatonia / Hypoactive delirium 
 Based on information from Morenski et al. 2003, Hills 2010, Wijdicks et al. 2010 and 
Arbour 2013.   
 
 
6.2.4. Peripheral nerve or muscle dysfunction 
Peripheral nerve or muscle dysfunction and neuromuscular blockade potentially play a role in 
inducing unresponsiveness in patient, and it could be a confounding factor in BD diagnosis. 
 
6.2.5. Clinically significant drug intoxications (e.g. alcohol, barbiturates, sedatives, 
hypnotics) 
Central nervous system-depressant drugs should be ruled out if the clinical history is 
indicative. It is therefore mandatory that the drug history be carefully reviewed, and if there is 
any possibility of intoxication being the cause of, or contributing to, the patient’s comatose 
state, it precludes a diagnosis of BD. In this case, drug screens are only supportive when 
tests are performed for a specific drug. Depressing drugs may have prolonged action, 
particularly when hypothermia coexists, or in the context of renal or hepatic failure. 
Nonetheless, therapeutic levels or therapeutic dosing of anticonvulsants, sedatives, and 
analgesics do not preclude the diagnosis. Regarding barbiturates, BD diagnosis most likely 
can be determined with sub therapeutic levels, even though reliable research in this area is 
lacking. In brain dead neonates and children, an isoelectric EEG remains, even 
decrementing from therapeutic to sub therapeutic levels of barbiturates. 
 
6.3. Criteria of brain death: Loss of cerebral hemispheric function (Deep 
unresponsive coma)  
       
Consciousness and responsiveness (wakefulness) reflects intact function of 
neurotransmitters and the ascending reticular activating system connecting the pons, 
thalamus, and midbrain with the diencephalon and cerebral cortex (De Ribaupierre 2011). As 
mentioned above, neurological evaluation must be done first to determine the cause of 
depressed consciousness. Taking a through history and identifying brain trauma, 
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hemorrhage, ischemia, and/or hypoxic or anoxic injury is appropriate as soon as possible, 
even before a brain death protocol is started. 
Assessment of consciousness and responsiveness may be done initially by 
using the Glasgow Coma Scale (GCS) score. A score of 3 (no eye opening, no verbal 
response and no movement either spontaneously or in response to stimulation) indicates 
complete loss of consciousness and responsiveness to noxious stimuli, which reflects severe 
brain dysfunction.  
The diagnosis of deep unresponsive coma requires that a comatose patient 
show a lack of spontaneous movements in addition to an absence of motor responses 
mediated by stimuli applied within the cranial nerve distribution (Wijdicks 2001a, Truog & 
Flacker 2006). Thus, unresponsiveness to noxious stimuli should be assessed by application 
of central pain stimuli, such as pressure on the supraorbital notch or temporo-mandibular 
joint or both. Findings consistent with BD are no facial movements or grimacing in response 
to noxious stimuli (Hills 2010, Wijdicks et al. 2010). 
 A loss of cerebral hemispheric function is evidenced by total loss of 
consciousness and responsiveness to all stimulation mediated above the spinal cord, and 
lack of arousal, awareness, such as cognition, perception, speech, voluntary movements and 
facial expressions as well as lack of sleep-wake cycles (Hills 2010, Wijdicks et al. 2010). 
 An unresponsive state of coma implies a complete lack of the above-mentioned 
CNS response to any kind of external and internal excitation (Wijdicks et al. 2010). A brain-
dead patient is, by definition, in an irreversible coma with total absence of awareness of self 
and environment despite external stimuli. This state differs from stupor, in which the patient 
requires continued stimuli to maintain consciousness. Quite vigorous stimuli might be 
required to reveal this difference. Furthermore, coma differs from a persistent vegetative 
state, in which the patient achieves sleep-wake cycles with eye opening but lacks cognitive 
awareness (Plum & Posner 1989). 
 If noxious stimulation elicits a purposeful motor response or posturing, BD is promptly 
ruled out. The brain dead can neither exhibit a purposeful motor response, such as 
localization, nor posture. Both the decorticate “flexion” and decerebrate “extension” postures 
originate in the brain stem, and their presence rules out complete brain stem failure and 
impedes BD diagnosis (Morenski et al. 2003). 
In the original Harvard Committee Report, absent spinal reflexes was one of the 
diagnostic criteria of BD. However, later it was documented that some BD patients may 
present spinal reflexes or motor responses, confined to spinal distribution, which, also, do not 
preclude the BD diagnosis (Morenski et al. 2003, Wijdicks et al. 2010). The spinal cord 
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generates a number of complex movements, such as rapid withdrawal of the lower 
extremities, in response to peripheral pain stimuli. While these responses may seem 
purposeful, careful examination reveals their reflexive nature, and their presence does not 
exclude the possibility of BD. Furthermore, one cannot rely on peripheral pain when the 
patient has suffered a spinal cord injury.  In BD, plantar responses, finger jerks, undulating 
toe flexion, muscle stretch reflexes, abdominal reflexes, triple flexion response, pronation-
extension reflex, Lazarus sign and facial myokymia have been described (Saposnik et al. 
2005). 
 
6.4. Criteria of brain death: Loss of brain stem function 
 
The next step in determining BD is assessing brain stem and cranial nerve function. As 
mentioned above, both the decorticate “flexion” and decerebrate “extension” postures 
originate in the brain stem, and their presence rules out complete brain stem failure 
(Morenski et al. 2003). 
In order to assess brain stem function, most of the clinical exam evaluates the 
brain stem reflexes. Cranial nerve dysfunction occurs later in the progression of severe 
intracranial hypertension, because of increasing pressure on the brain stem, tissue distortion 
and deformation of cranial nerve roots (Arbour 2013). Table 3 summarizes brain stem 
assessment and findings consistent with BD. 
 
6.4.1. Pupillary tests 
Examination of the pupils of the eye is critical in clinical determination of BD (Arbour 2013).  
Facial and ocular trauma may compromise the ability to perform an optimal bilateral pupillary 
examination. Pupillary assessment must also take into account medications the patient has 
received, such as topical atropine for eye examination or intravenous atropine during cardiac 
arrest. Drugs may influence the size of pupils but generally do not eliminate the reflex, 
although the clinician may need a magnifying glass to perceive the reaction (Morenski et al. 
2003). 
The pupillary light reflex involves cranial nerves II and III. It localizes 
anatomically to the midbrain. Normally, both pupils constrict in response to light. “Fixed and 
dilated” pupils result from intact sympathetic fibres that arise from the cervical spinal cord and 
innervate the pupillary dilators. Damage to the midbrain often results in “midposition” (4-6 
mm) pupils from damage to the parasympathetic Edinger-Westphal nucleus. Damage to the 
pons results in “pin-point” pupils from damage to the descending sympathetic fibres, which 
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allows the midbrain parasympathetic Edinger-Westphal nucleus to control size. Since 
completely pin-point pupils imply a functional Edinger-Westphal nucleus, their presence is not 
compatible with brain death. The pupil size of a brain-dead patient may therefore vary 
depending on the sequence of damage. The pupillary reflex, both direct and consensual, 
should be explored in both eyes using a bright light. The crucial part of the test is whether the 
pupil reacts to light; the brain-dead patient will have nonreactive pupils. 
 
Table 3. Brain stem assessment during determination of brain death.  
Brain stem 
reflex 
Cranial nerve(s),  
Brain areas tested 
Examination technique Findings consistent 
with brain death 
Pupillary light II, optic 
III, oculomotor 
Midbrain 
Assess pupillary size and shape in slightly 
darkened room: shine a bright light into each 
eye and assess reaction (or it’s absence) in 
each eye 
Pupils dilated to a possible 
range of 4-9 mm diameter, 
nonreactive to bright light, 
and midposition within the 
orbit 
Corneal                III, oculomotor 
V, trigeminal 
VII, facial 
Pons 
Lightly brush cornea with sterile cotton 
swab 
No eye blink in response to 
corneal stimulation 
Oculocaphalic III, oculomotor 
IV, trochlear 
VIII, vestibulocochlear 
Pons and midbrain 
After spinal cord injury, other 
contraindication ruled out: rapidly rotate 
patient’s head to either side and observe for 
eye movement relative to orbit 
No apparent eye movement 
within the orbit 
Oculovestibular 
(cold calorics)      
III, oculomotor 
IV, trochlear 
VI, abducens 
VIII, vestibulocochlear 
Pons and midbrain 
After tympanic membrane rupture, other 
contraindications, and cerumen deposits 
ruled out: elevate head of bed to 30° (if no 
contraindications to doing so), irrigate each 
ear canal in turn with 50 mL of ice water, 
observe for eye movement/deviation 
No eye movement for 1 
minute after irrigation of 
each ear canal 
Cough/gag      IX, glossopharyngeal 
X, vagus 
Medulla 
Gag reflex: stimulate deep posterior pharynx 
(oral/pharyngeal suction device) 
Cough reflex: use deep endotracheal 
suctioning to depth of carina (2 passes with 
suction catheter 
No response to either 
stimulation 
Besed on information from Morenski et al. 2003, Hills 2010, Wijdicks et al. 2010, and Arbour 2013. 
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6.4.2. Corneal reflex 
The corneal reflex involves cranial nerves III, V and VII and localizes anatomically to the 
entire pons. In the intact patient, unilaterally touching the cornea with a cotton swab 
(stimulation) causes a bilateral closure of the eyelids.  This is also one of the most 
discriminant reflexes in BD diagnosis. A bilateral or unilateral response of eyelid closure and 
upward deviation of the eye (Bell’s phenomenon) indicates preserved brainstem functioning. 
The brain-dead patient demonstrates no response. However, edema or drying of the cornea 
and severe facial and ocular trauma may preclude a satisfactory stimulus for this reflex. 
 
6.4.3. Oculocephalic reflex 
Often confusingly referred to as the “doll’s eyes” response, this reflex involves cranial nerves 
III, IV and VIII and interneurons within the pons and midbrain. In an intact patient, the eyes 
remain “fixed” on a point during head movement. Rotation to the right requires right-eye 
adduction and left-eye abduction. Head flexion and extension tests cranial nerve IV. Prior to 
performing the test, the physician must rule out a cervical spine fracture and instability, or use 
a rotation bed. Damage to the relevant areas result in fixed eye position. In the brain-dead 
patient, the eyes move with the head. 
 
6.4.4. Oculovestibular reflex 
The oculovestibular reflex involves cranial nerves III, IV, VI and VIII. It involves the entire 
pons and midbrain. While an interesting test, it does not really add to the exam since the 
pupillary, corneal and oculocephalic reflexes cover the same areas anatomically.  It also 
presents a potential for confusion. Although medical students and physicians learn the 
acronym COWS for “cold opposite, warm same” to remember the direction of the apparent 
nystagmus, this is not the response seen in a comatose or brain-dead patient. With the use 
of cold water as stimulus, the eyes tonically deviate toward the side of the stimulus. The 
“nystagmus” – the rapid correction to the opposite side – comes from area 8 of the ipsilateral 
frontal lobe, the frontal eye fields, as it attempts to counteract the deviation. Since comatose 
patients do not have functional frontal lobes, only the tonic deviation toward the cold stimulus 
or away from a warm stimulus is seen. Absence of any eye movement is consistent with 
brain stem failure at the level of the pons and midbrain. 
 The following are steps to perform the test: 
1. Elevate the head 30°. 
2. Fill 50-cc syringe with iced water or saline. 
3. Attach 16-gauge IV catheter with the needle removed. 
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4. Irrigate tympanic membrane. 
5. Wait 1 minute for response. 
6. Wait 5 minutes before testing other side.  
 
6.4.5. Gag (pharyngeal) and Cough reflexes 
The gag and cough reflexes test cranial nerves IX and X, and require a functional medulla. 
These reflexes are often difficult to explore because of the presence of tubes in the throat 
and dryness of the mucosa. To test the gag reflex, the physician must stimulate the posterior 
pharynx with a tongue blade or cotton-tip applicator. The cough reflex requires stimulation of 
the carina by suction through the endotracheal tube. Brain-dead patient will not have a gag or 
cough reflex. A potential pitfall results from failure to suction the patient to his carina. Merely 
manipulating the endotracheal tube may fail to generate a reflex. 
 
6.4.6. Atropine test 
The atropine test assesses bulbar parasympathetic impact on heart activity in a brain dead 
patient. This test proposes using atropine to explore bulbar activity for differentiating coma 
from so-called brainstem death. The test consists of injecting 2 mg of atropine under 
continuous monitoring with the electrocardiogram (ECG) for 10 minutes. The atropine test is 
considered negative, confirming BD, if the heart rate does not augment by more than 3% 
compared with based ECG records. It should be applied after the patient meets other clinical 
BD criteria.  
There are, however, some limitations to the atropine test. An infratentorial lesion 
or a brainstem lesion may cause damage to the dorsal vagal nucleus, resulting in a negative 
test result independent of BD.  Moreover, the test is not applicable in case of autonomic 
neuropathy and in patients who have undergone cardiac transplantation with denervation of 
autonomic fibers to the heart. Nonetheless, as this test explores parasympathetic arcs 
through the medulla oblongata, and it is simple to apply, its inclusion is recommended in BD 
diagnostic protocols (Wijdicks 2001a). 
 
6.4.7. Apnea testing 
The apnea testing (AT) is the final clinical test. The rationale behind the AT is to demonstrate 
failure of the medullary centers to drive ventilation. It is an essential sign of a definitive loss of 
brainstem function and implies that breathing has become extinct. Nonetheless, it is the most 
difficult, potentially harmful and lengthy clinical test in BD protocols. This test may induce 
hypotension, excessive hypercarbia, hypoxia, acidosis, cardiac arrhythmia or asystole, but it 
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is the decisive clinical test in brain death diagnosis. An examiner with experience can apply 
this test in 99.9% of all cases; the remaining ones may be studied using other ancillary tests 
(Machado 2007b).  
Apnea testing is generally performed after the cause of coma, 
unresponsiveness, and lack of brain stem reflexes is established. Of interest, it was noted 
that “No report has been published of either an adult patient or child who, with otherwise 
absent brainstem reflexes but spontaneous breathing, ’recovers’ to a persistent vegetative 
state or better” (Wijdicks 2001a). More appropriately, no report has been published of either 
an adult or pediatric patient who demonstrates absent brain stem reflexes but spontaneous 
breathing able to maintain adequate ventilation without mechanical support (Morenski et al. 
2003). 
Prior to the test, the physician ensures the patient has met the other clinical 
criteria, which include adequate hemodynamic status, core temperature and absence of 
drugs and metabolic derangements. Thus, before applying AT some prerequisites should be 
considered to minimize risk of complications (Table 4): 
● A pretest systolic blood pressure of at least 90 mmHg is recommended, 
● Body temperature at 36 or 36.5C is recommended. Hypothermia correction facilitates 
CO2 production and reduces the changes of hypotension by stabilizing blood pressure and 
the hemodynamic state, 
● Normal arterial PCO2 or PaCO2 range of 35-45 mm Hg is recommended. It was remarked 
that the main issue is to consider starting 20 mmHg above the normal baseline level. The 
combination of  hypoxia with hypercarbia provides a greater ventilator drive (Morenski et al. 
2003). However, the resulting acidosis from extreme hypercarbia may cause hemodynamic 
compromise, while hypoxic stimulus risks generation of hypoxic brain injury in a patient who 
is not brain dead, as well as hypoxic-ischemic injury to potentially transplantable organs. In 
cases with a higher PaCO2 than normal baseline level, as seen in patients suffering from 
chronic obstructive pulmonary disease, guidelines suggest a value of 20 mmHg higher than 
the baseline (the Quality Standards Subcommittee of the American Academy of Neurology 
1995), 
● A normal pH or a value in the low basic range is recommended, 
● Fluid balance: euvolemia or a positive fluid balance during the previous 6 hours is 
recommended, 
● There are no clear PaO2 recommendations except preoxygenation with 100% O2 for 
roughly 10 minutes, and avoidance of hypoxia. Preoxygenation helps to correct possible 
hypocapnia, often due to hyperventilation or provoked by high tidal volumes of the 
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mechanical ventilator, or due to hypothermia. It will eliminate alveolar nitrogen stores and 
facilitate oxygen transport (Wijdicks et al. 2008). Preoxygenation also helps to avoid 
desaturation during the AT and its associated cardiovascular effects. In addition, the level of 
preoxygenation may be adjusted to obtain a starting PaCO2 of approximately 40 mmHg to 
shorten the period of apnea. A normal PO2 or preoxygenation to obtain an arterial PO2 ≥ 200 
mmHG is recommended, 
● Medication: apnea testing must not be performed under the influence of drugs that can 
paralyze respiratory muscles, such as relaxants. 
 
6.4.7.1. Procedure of Apnea Test 
Two techniques for ascertaining sufficient oxygenation during apnea testing are used. The 
physician may either disconnect the mechanical ventilator and place a large bore catheter 
down the endotracheal tube to deliver 100% oxygen, or maintain the patient on continuous 
positive airway pressure (CPAP) through the respirator circuit. Both methods have their 
advantages and disadvantages, and the choice depends on the experience of the physician 
and respiratory therapy staff. In addition, these techniques may be used to obtain a starting 
PaCO2 of approximately 40 mmHg to shorten the period of apnea. 
Hence, the first technique is disconnection of the patient from the respirator and 
insertion of a catheter or cannula into the endotracheal tube down to the level of the carina, 
providing pure oxygen at a flow rate of 6 to 10 L/minute during 4 and 10 minutes. This 
ensures sufficient ventilation into the alveoli and transporting oxygen to the blood even 
without any respiratory movements (Wijdicks 2001a, Wijdicks et al. 2008).   
The diameter of the insufflation on the catheter should be approximately 14F to 
16F or slightly larger and should not occlude the airway. While use of large bore insufflation 
catheter may help avoid inadequate oxygenation, use of a too large insufflation catheter may 
lead to inadequate egress of air and may lead to barotraumas, pneumothorax or 
subcutaneous emphysema.  
 
Table 4. Preparatory steps before apnea testing. 
Steps Method Rationale 
Stabilize systolic blood pressure 
≥90 mmHg   
Appropriate titration of inotropic 
and/or vasoactive agents 
Optimizes cardiovascular stability, 
tissue perfusion, and physiological 
reserve 
(Necessary due to loss of vasomotor 
tone) 
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Stabilize body temperature 
≥36.5C (preferred). 
(Apnea testing can be done at lower 
temperatures, but additional time 
required for an increase in CO2, 
risking cardiovascular instability) 
Use of heating blankets, infusion of 
warmed intravenous fluid, heat 
lamps 
Hypothermia suppresses neuronal 
activity, including at brain stem level, 
and prolongs duration of action for 
central nervous system depressants 
and neuromuscular blockers 
Normalize PaCO2 to range of 35-45 
mmHg 
Downward titration of controlled 
ventilation (tidal volume/ventilator 
set rate), unless contraindicated, to 
attain normocarbia/baseline PaCO2 
Baseline arterial CO2 level establishes 
a starting point for CO2  measurement 
at intervals. 
Beginning with hypocarbic state will 
require additional time for CO2 
increase and increase risk for 
cardiovascular instability 
Maintain adequate circulating blood 
volume 
Appropriate administration of 
crystalloid, colloid, and/or blood 
products to replace volume losses 
and correct absolute/relative 
hypovolemia 
Stabilizes cardiovascular/blood 
pressure during the stress of apnea 
testing 
Administer 100% oxygen for ≥10 
minutes to PaO2 ≥200 mm Hg 
Fraction of inspired oxygen 1.0 
with positive end-expiratory 
pressure at 5 cm H2O. 
When pulse oximetry indicates 
stable oxygen saturation, sample 
arterial blood gases to document 
baseline level 
Facilitates oxygenation, eliminates 
nitrogen stores, and avoids oxygen 
desaturation and cardiovascular 
consequences 
Based on information from Wijdicks 2001a,  Hills  2010 ,   Wijdicks et al. 2010,   Wijdicks et al. 2008, and  Scott et 
al. 2013. 
 
In the second technique for ascertaining sufficient oxygenation during AT, the 
patient is not disconnected from the respirator but the volume is decreased to a very low 
level (controlled hypoventilation from 0.5 to 2 L/minute), using synchronized intermittent 
mandatory volume ventilation and providing pure oxygen for inspiration; in this way, the 
patient is not disconnected until the required PaCO2 is achieved. This method prevents 
tracheopulmonary complications and still allows the examinator to detect any spontaneous 
breathing movement (Machado 2007b).  It was considered that it is safer to test the apnea by 
leaving patients on a continuous flow of 100% oxygen and low peak end-expiratory pressure 
(PEEP) than to disconnect them from the respirator (Machado 2007b).  However, maintaining 
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the patient on CPAP can give the false impression that the patient is breathing if the 
sensitivity of the ventilator is not appropriately adjusted. Hence, examples were noted with 
significant false readings of spontaneous respiratory rates of 20 to 30 breaths/min by the 
mechanical ventilator sensors, with CPAP settings as low as 2 (Wijdicks 2001a, Wijdicks et 
al. 2008).  
The AT result is positive, supporting a BD diagnosis, when no breathing effort is 
observed at a PaCO2 of 60 mmHg or with a 20 mmHg increase from baseline. A true 
spontaneous breath consists of abdominal or chest excursions that produce adequate tidal 
volumes (Wijdicks 2001a, Wijdicks 1995).  In contrast, if the patient demonstrates 
spontaneous respiration at any time, the apnea test is considered “negative”, not supporting 
a BD diagnosis, and the patient should be connected again to the mechanical respirator.  
If arterial pressure becomes <90 mmHg, or a noticeable desaturation is 
detected by the oximeter, or cardiac arrhythmias take place, the AT procedure should be 
stopped and the mechanical respirator should be re-connected. Fixed durations of AT are not 
considered standard anymore, and arterial blood gas determinations are used to formally 
document PaCO2 to prescribed thresholds and the absence of intrinsic respiratory drive 
(Wijdicks 2001a, Morenski et al. 2003, Hills 2010, Wijdicks et al. 2010,  Scott et al. 2013). 
The first baseline arterial blood gas is drawn after about 10 minutes. Should the initial PaCO2 
not equal, or exceed 60 mmHg or 20 mmHg above the patient’s baseline, the physician can 
then obtain another baseline arterial blood gas. The patient’s failure to demonstrate 
spontaneous breathing with a PaCO2 equal to or greater than 60 mmHg or 20 mmHg above 
his baseline constitutes a “positive” test and is consistent with BD. There is “little scientific 
evidence to support raising the target value for PaCO2 beyond 60 mmHg or 20 mmHg above 
the patient’s baseline (Morenski et al. 2003). 
 
6.4.7.2. Complications of apnea test 
Inadequate preoxygenation has a clear association with an increased number of 
complications. Hypotension is the most frequent complication in 24% of cases, while cardiac 
arrhythmias with the potential for ventricular fibrillation or arrest is much less common (1%) 
(Machado 2007b).  
The following are the main reported complications: 
● Excessive hypercarbia. CO2 values over 120 mmHg cause necrosis and should be 
avoided, although general recommendation do not exist, and there are no generally accepted 
PaCO2 values for patients whose natural respiration is adapted to a PaCO2 of more than 45 
mmHg. In these cases, other ancillary tests are recommended (Lang & Heckmann 2004). 
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● Hypoxia. O2 values less than 70 or 60 mmHg should be avoided. If pulse oximetry is used, 
values should not drop below 80%. It has been suggested that hypoxemia contributes to 
cardiac arrhythmia or hypotension during AT (Ropper et al. 1981). 
● Respiratory acidosis. There are no precise recommendations for the pH, although pH 
values less than 7.2 or 7.0 should be avoided. Its fall is highly correlated with the increase of 
PaCO2 and it is rapidly restored with normoventilation or mild hyperventilation. Lower values 
of pH (as low as 6.8) during AT  should not be corrected by buffer or alkaline solutions, 
because alkalosis will result after normoventilation; as an alternative, a normal pH or value in 
the low basic range should be established at the onset of AT (Lang & Heckmann 2005). 
● Hypotension. Blood pressure values of less than 60 or 70 mmHg systolic, 40 mmHg 
diastolic, and mean arterial pressure of 50 mmHg should be avoided. The presence of a 
blood pressure of 90 mmHg before testing is acceptable as a rule. Usually there is a mild 
increase of blood pressure with hyperoxygenation and a somewhat more marked decrease 
with hypercapnia. Persistent hypotension may be corrected using intravenous fluids, 5% 
albumin, or an increase of intravenous dopamine or (nor)epinephrine. 
● Cardiac arrhythmia and arrest. Cardiac arrhythmias induced by AT are rare (Goudreau et 
al. 2000) and cardiac arrest occurring only in two of 63 cases (Saposnik et al. 2004). It 
should be avoided at any rate. Arrhythmias are mostly due to excessive acidosis or to 
hypoxia, which can be suspected by the onset of new cardiac arrhythmias or a noticeable 
drop in heart rate (Lang & Heckmann 2005). 
● Barotrauma. Barotrauma is considered extremely rare (Saposnik et al. 2004). Tension 
pneumothrorax and pneumoperitoneum may ensue after massive oxygen insufflations into 
the endotracheal tube with an oxygen supply that obliterates the tube or a valve mechanism 
that makes the escape of the insufflated gas impossible (Vivien et al. 2001). 
● Increase of intracranial pressure. Intracranial pressure (ICP) is usually not monitored 
during AT except in some neurosurgical intensive care units. Since theoretically AT may 
increase ICP via local hypercapnic vasodilatation and the ensuing increase of cerebral blood 
volume, this test should be the last of all clinical tests (Lang & Heckmann 2004). 
 When a reliable AT is impossible to achieve, due to the unfeasibility of reaching the 
target PaCO2, or when an unsafe drop in PaO2 is inevitable, or in patients with severe thorax 
trauma or other pulmonary problems, other ancillary tests should be used. 
 
6.4.7.3. Timing of second exam 
The period of observation between BD examinations depends on the clinical aspects, the use 
of confirmatory tests and the age of the patient. As presented in Table 1. an observation 
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period of 6 hours in adults is recommended (Wijdicks 2001a).  The repeat exam includes the 
brain stem reflexes as in the first examination but does not require repeat apnea testing. As 
discussed in the section on the apnea trial, no report exists of either an adult or pediatric 
patient who met the criteria of brain death clinically and received an appropriately performed 
apnea test, who then went on to achieve any neurological recovery. Furthermore, a patient 
may not tolerate a second apnea testing. However, individual physicians and institutions are 
free to perform a repeat apnea testing, as they are free to obtain confirmatory tests. 
 
7. Confirmatory tests in brain death declaration process  
 
It is widely accepted that BD is a clinical diagnosis, and that confirmatory tests are not 
mandatory in most situations. However, in certain countries, including Croatia, the law 
requires confirmatory tests. Finally, individual institutions may require confirmatory tests as 
part of their protocol for establishing a BD diagnosis (Machado 2007b, c]. 
The confirmatory tests provide invaluable assistance with the complex medical 
and social aspects of BD. Properly chosen and performed, confirmatory tests are essential 
when doubt exists about the clinical findings, conditions preclude an apnea test or suspicion 
of confounding conditions exists. The confirmatory tests can shorten the interval before the 
second test based on clinical judgment (Wijdicks 1995). However, despite this there is no 
global consensus in choice of confirmatory tests in BD declaration process. An ideal 
confirmatory study for BD should be safe, extremely accurate and reliable, available, quick 
and inexpensive (Machado 2007c). 
Clinical judgment must enter into situations that include the hemodynamically 
unstable patient who does not respond to resuscitation efforts. Such patients may not tolerate 
an apnea test and may not survive even the 6-hour period. A similar clinical picture can follow 
acute overdoses of benzodiazepines, barbiturates and opiates. Furthermore, less certain 
remains the case of the patient who has not passed the period necessary for elimination of 
the drugs. Patients, who receive “pentobarbital coma” therapy to achieve 
electroencephalographic burst suppression, in a final effort to control ICP, present a similar 
problem. The physician faces a possible waiting period of days before the serum 
pentobarbital level decreases sufficiently. In cases of severe head injury, the clinical history, 
exams, and an inability to maintain ICP at levels compatible with life, even with institution of a 
pharmacologic coma, justify the addition of confirmatory tests. 
Confirmatory tests in BD can be divided into those that prove absent cerebral 
and brain stem blood perfusion, and those that demonstrate loss of brain bioelectrical activity.  
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Among tests that demonstrate a complete cessation of brain blood flow, the 
following are included: 
● bilateral carotid and vertebral contrast angiography (cerebral four-vessels angiography),  
● cerebral intravenous digital subtraction angiography,  
● intravenous radionuclide angiography using a gamma camera, 
● single photon emission computed tomography (SPECT),  
● transcranial doppler (TCD) ultrasonography,  
● computed tomographic (CT) angiography, and  
● magnetic resonance (MR) angiography.  
Among tests that demonstrate a loss of brain bioelectrical activity, the following 
are included: 
● digital continuous EEG monitoring,  
● multimodal evoked potentials (MEPs), such as visual evoked potentials (VEPs) and 
electroretinography (ERG), brainstem auditory evoked potentials (BAEPs) and  short latency 
somatosensory evoked potentials (SEPs) have been used.  
In fact, confirmatory tests that are widely accepted are conventional cerebral 
four-vessels angiography and EEG. Instead of that, combining of transcranial doppler (TCD) 
ultrasonography and a neurophysiological test battery (EEG, MEPs  and electroretinography 
(ERG) (Table 1) have been recommended recently (Machado 2007c). 
 
8. Brain death in children 
  
Although pediatric BD diagnosis encloses the same concept and similar diagnostic procedure 
as in adults, it is a more difficult task for physicians and nurses because of several ethical 
and psycho-emotional issues. Parents and the general population are more reluctant to 
accept death in children, and find it difficult to understand an explanation that a child with 
preserved heartbeats but no brain activity is dead (Ashwal 2011).  
 Moreover, the clinical exam of suspected brain-dead pediatric patients is more difficult 
to carry out because of the smaller size of the patient, the immaturity of the reflexes that 
change with central nervous system (CNS) maturation, and the existence of fontanels and 
open sutures in neonates and infants. 
 The most frequent etiology of BD in children is trauma, due to motor vehicle 
accidents, shaken baby syndrome and abuse. Asphyxia producing anoxia is also a common 
cause, in home accidents such as near drowning, suffocation, and from the so-called sudden 
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infant death syndrome (SIDS). Some massive infections of the brain can also be the origin of 
permanent destruction of CNS structures (Ashwal 2011). 
 The current guidelines (Table 5) derive from the 1987 report of a special task force 
composed of representatives of the pediatric, neurologic and legal disciplines (Task Force for 
the Determination of Brain Death in Children 1987a, b]. These guidelines which have been 
widely introduced in pediatric hospitals are presented in Table 5. 
 
Table 5. Guidelines for brain death determination in children 
A. History: determine the cause of coma to eliminate reversible conditions 
B. Physical examination criteria: 
1. Coma and apnea. 
2. Absence of brainstem function. 
     a. Mid-position or fully dilated pupils. 
     b. Absence of spontaneous oculocephalic (doll’s eye) and caloric-induced 
eye movements. 
     c. Absence of movement of bulbar musculature, corneal, gag, cough, 
sucking and rooting reflexes. 
     d. Absence of respiratory effort with standardized testing for apnea. 
3. Patient must not be hypothermic or hypotensive. 
              4. Flaccid tone and absence of spontaneous or induced movements, 
excluding activity mediated at spinal cord level. 
              5. Examination should remain consistent for brain death throughout the pre-
determined period of observation. 
C. Observation period according to age: 
              1. age of 7 days to 2 months:  
                  Two examinations and EEGs 48 hours apart 
              2. age of 2 months to 1 year: 
                  Two examinations and EEGs 24 hours apart, although the repeat exam 
and EEG is not necessary with an initial EEG showing electrocerebral silence (ECS) 
combined with a radionuclide angiography showing no cerebral blood flow (CBF). 
              3. older than 1 year: 
                  Two examinations 12 to 24 hours apart, EEG and radionuclide 
angiography are optional; multimodality evoked potentials (MEPs) and transcranial 
Doppler ultrasonography (TCD) can be used as confirmatory tests to shorten periods 
of observation. 
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Compared with BD diagnostic criteria in adults, these guidelines do not differ in 
any important way. The main differences are the age related periods of observation and 
requirement of particular confirmatory tests in children under 1 year of age. As in adults, in 
children over 1 year of age, the diagnosis is based on clinical examination and confirmatory 
tests are not mandatory. However, the commission has also proposed the use of confirmatory 
tests to shorten the period of observation in children older than 1 year (Task Force for the 
Determination of Brain Death in Children 1987b). Ashwall has proposed BD criteria for term 
infants younger than 7 days of age (Ashwal & Serna-Fonseca 2006). One of the differences 
with adult BD protocols is the exploration of brainstem reflexes, because the maturation of 
the nervous system entails different periods of time for a specific reflex to be fully developed. 
The pupil light reflex is only present after 30 weeks gestation and the oculocephalic response 
is absent before 32 weeks. 
 
9. Patient’s family care 
 
Advocacy, honesty and the development of trust between the patient’s family and personnel 
on the health care team markedly promote communication and rapport during a stressful and 
difficult time. Family members of a patient with a devastating brain injury are under stress 
and need empathy, teaching and an environment of trust. It is crucial to establish trust and 
help the family to understand the torrent of information from multiple health care providers. 
Taking time and building on the trust established upon ICU admission can help the family 
understand brain injury, progression of the injury and what BD means. All these 
considerations are vital, with or without organ recovery, organ donation and transplantation 
as possible end points. 
 Allowing time and resources, including spiritual support or chaplains, when formal 
brain death protocols are being contemplated or initiated, gives a patient’s family members 
an opportunity to process their experiences. Encouraging family members to speak and ask 
questions during meetings is associated with families’ satisfaction, whether or not organ 
donation is considered in end-of-life discussion. Facilitating early visiting with the patient and 
providing realistic and honest communication about his or her condition and prognosis, in 
ways a family can understand, are vital. When brain injury is refractory to aggressive 
management to control the consequences of injury, such as ICP elevation, and the patient 
progresses toward BD, empathy and honesty are important in communicating this decline to 
the patient’s family. At this stage, with a worsening neurological status, specific clinical 
triggers may be met to initiate referral of a potential donor to the organ procurement 
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organization. The triggers may include a decrease in the GCS score, or loss of one or more 
brainstem reflexes, or both. The representative of the procurement organization has no direct 
involvement in clinical management of the patient until BD is formally declared and consent 
has been obtained for organ donation. A conflict of interest can occur if direct involvement by 
an organ procurement organization is involved in the management of the patient, before the 
declaration of BD is confirmed. Any family discussion should start with a thorough 
explanation of the patient’s grave condition and should include definition of terms. Providing a 
clear definition of BD and ensuring the family’s understanding before organ donation is 
discussed, are vital to avoid later misunderstanding (Murthy 2009). Communication with 
family members after completion of a BD protocol needs to be unequivocal that BD has 
occurred and that the patient is in fact dead (Murthy 2009). The dead-donor rule requiring 
declaration of death before organ recovery for transplant can then apply (Truog & Robinson 
2003). 
 Any discussions with a patient’s family should take into account cultural and religious 
perspectives and how family members define death. BD may have variable meanings for 
individuals. One meaning may be severe brain injury. Another may be unawareness of 
surroundings. Establishing how family members perceive death is an optimal starting point 
for exploring organ donation. Religious issues are of utmost importance in discussing BD. 
Most religions, including Christianity, Islam, Judaism and Hinduism support organ donation 
as a charitable and helping act. Understanding the religious perspectives of the family of a 
potential donor can better prepare health care providers for discussions about BD. The need 
for careful choice of words and use of the same terminology by all members of the health 
care team in discussing brain death with the patient’s family cannot be overstated (Savel & 
Munro 2012). 
 
10.  Case report 1 
 
Mr. P.Š., a 73-year old male, suddenly developed left sided facial paresis, along with 
sweating and weakness, at 10.45 a.m. on the 2016.09.16, witnessed by his wife. He 
proceeded to take a shower but collapsed in the washing room. His wife activated the 
emergency medical system. After transport to the emergency department, evaluation 
revealed dyspnea, decreased consciousness and left sided hemiplegia. His medical history 
included recently diagnosed and untreated diabetes mellitus type 2, arterial hypertension and 
atrial fibrillation. A non-contrast CT scan of the head revealed the right sided zone of sub-
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acute occipital ischemia (Figure 1), along with a cerebral CT angiography, which confirmed a 
finding consistent with basilar artery occlusion. 
 
 
Figure 1. A non-contrast CT scan showing extensive ischemic lesions in the brainstem, as 
well as the entire area supplied by the right posterior cerebral artery. 
 
Firstly, the patient urgently underwent intravenous thrombolysis with tissue 
plasminogen activator and after that, a mechanical thrombectomy was attempted. At this 
time, P.Š. was in deep coma (GCS 3) with miosis of symmetrical sized pupils, decerebrate 
posturing on painful stimuli, tachyarrhytmic, breathing spontaneously with airway in place, but 
multiple crackles on lung auscultation and regurgitated content in the oral cavity. A cerebral 
angiography showed sub-occlusive stenosis at the transition from the proximal onto middle 
third of the basilar artery, at a length of 3 mm, proximal to the origin of the anterior inferior 
cerebellar artery, through which the contrast had a delayed flow and marked out the thrombi 
distally in the middle third of the basilar artery (Figure 2). Multiple attempts were made to 
pass through the point of stenosis, but ultimately failed. Due to the same cause, the point of 
stenosis could neither be dilated with a balloon catheter, which resulted in a failed attempt 
and the patient was transferred back to the neurological ICU for medical management. 
 
 
 
 
 
 
26  
 
Figure 2. Digital subtraction 
angiography of the vertebrobasilar 
circulation, showing basilar artery 
stenosis  with basilar artery occlusion 
in proximal parts and migrated 
thrombus distally. 
 
 
 
 
 
 
 
 
A control CT was performed 3 days later, which showed an extensive ischemic lesion 
affecting the entire cerebellum and brain stem, as well as the entire area supplied by the right 
posterior cerebral artery, including the right thalamus (Figure 3). In addition, the territory of 
the left posterior cerebral artery was affected, as well as both anterior cerebral arteries. The 
brain edema caused narrowing of the IV ventricle and tonsillar herniation of the brain 
parenchyma, with consequent development of obstructive hydrocephalus.  
 
 
Figure 3. Same CT scan, 
also showing ischemia of 
complete cerebellum. 
 
 
 
 
 
 
 
 
 The patient had diffuse ischemic lesions of both the brain and brain stem. He 
remained in a comatose state on the fifth day of admission, with dilated, non-reactive pupils, 
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along with all the clinical signs consistent with BD. Additionally, at 04.00 p.m., the results of 
auditory evoked potentials and somatosensory evoked potential  (illustrated on Figure 4) 
were consistent with BD and the patient was declared dead at 04.00 p.m. on the 2016.09.21 
according to the Croatian Regulations on the Procedure and Medical Criteria Required for 
the Determination of Brain Death and Harvesting of Organs (»Narodne novine«, br. 177/04), 
see Annex. 
 
 
Fig. 4. The combined recordings of auditory brain stem responses (ABRs) (A) and 
somatosensory evoked potentials (SEPs) (B), after the clinical onset of brain death, shows 
absent potential response confirming the death of the brain stem (Facco et al. 2002). 
 
 
11. Case report 2 
 
Mr. F.M., a 62-year old male, was admitted to the emergency department, in the afternoon 
hours, on the 2017.02.03. His medical history included a previous cholecystectomy, 
untreated arterial hypertension, and suspected benign prostatic hyperplasia. Additionally, he 
was an alcoholic and a smoker.  
 Upon returning from work, his wife finds him unresponsive and having urinated 
himself, at home. She activated the emergency medical system, and the information given by 
her stated that last time he was seen awake and responsive was on the previous evening, 
before going to bed. At arrival at the emergency department, he was tachycardic, 
tachydyspnoic, hypoxic, with crackles on lung auscultation and febrile. He was in coma (GCS 
4), showed decerebration on painful stimuli, exhibited anisocoria (L > R), with the left pupil 
unreactive. Babinski sign was positive and he had diffuse elevated muscle tone of the 
extremities. A  CT of the head revealed massive hypertensive intracerebral hemorrhage in 
the region of the basal ganglia on the left, visible brain edema and blood penetrating into the 
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ventricular system (Figure 5). The hematoma caused a subfalcine herniation of the brain for 
14 mm. 
 
 
Figure 5. Non-contrast CT scan showing massive intracerebral and intraventricular 
haemorrhagia, also causing acute subfalcine herniation.  
 
 
F.M. was transferred to the intensive care unit (ICU). A conservative approach to 
treatment was decided and he was analgo-sedated, intubated and put on mechanical 
ventilation. He was given volume replacement therapy, with crystalloids, and his electrolyte 
disbalance was corrected. He received medication for gastric protection and empiric 
antibiotic treatment with ceftriaxone and vancomycin. The blood flow was monitored with 
transcranial Doppler (TCD) during the following days of hospitalization.  
 On day 2 of hospitalization, a repeat CT scan was performed, which showed no other 
changes to the radiological findings from before, apart from more pronounced brain edema 
(Figure 6). The next control CT scan, performed on the 7th day of hospitalization showed 
blood in the basal cisterns and brain stem (Figure 7). Also noted was the development of 
ischemia in the region supplied by the right middle cerebral artery, where the line between 
the grey- and white matter was blurred. Sub-arachnoidal hemorrhage was seen and 
development of tonsillar herniation. Further control CT scans on day 8 of admission showed 
still no radiological improvement of the state of the patient (Figure 8). 
 A clinical neurological assessment, which was performed on the 10th day of 
hospitalization, showed absence of brain stem reflexes. The patient was sent for a perfusion 
SPECT scan, with Technetium 99m hexametazine (Tc-99m HMPAO). The angioscintigram on 
axial, sagittal and coronal tomographs showed no signs of preserved blood flow through the 
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cerebrum, cerebellum or the brain stem, which is consistent with a diagnosis of BD (Figure 
9). The death of the patient was proclaimed at 12.30 p.m. on the 2016.02.13, according to 
the Croatian Regulations on the Procedure and Medical Criteria Required for the 
Determination of Brain Death and Harvesting of Organs (»Narodne novine«, br. 177/04), see 
Annex. 
 
Figure 6. On day 2 of 
hospitalization, a repeat CT scan 
was performed, showing nearly 
the same finding, apart from more 
pronounced brain edema. 
 
 
 
 
 
Figure 7. The next control CT 
scan, performed on the 7th day of 
hospitalization showed blood in 
the brain stem and all ventricles. 
 
 
 
 
 
Figure 8. Showing CT scan from 
the same patient, about 8 days 
after admission. No improvement 
of status, either in   clinical or 
radiological point of view. 
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Fig. 9. SPECT imaging 
in a brain dead patient. 
The figure shows axial 
(A), sagittal (B) and 
coronal (C) views of a 
brain in which there is 
complete cessation of 
blood flow (white) 
(Lorberboym M 2013). 
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13. ANNEX 
 
Legal determination and certification of human death in Croatia  
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